The pathogenetic substantiation of the neurostimulating treatment of metabolic syndrome in the patients presenting with erectile dysfunction

Abstract

Pharmacotherapy of erectile dysfunction in the patients presenting with metabolic syndrome is known to frequently produce the unstable effect of short duration because it fails to exert the polyvalent influence on the main regulatory systems. The investigations carried out during the recent years have demonstrated that the most pronounced therapeutic effect in the patients with metabolic syndrome can be achieved by applying the physiotherapeutic factors affecting all components of pathogenesis of this disease. Of great interest in this context is the use of neurostimulating therapy that exerts the positive influence on the cardiovascular and neuroendocrine systems, carbohydrate and lipid metabolism. Moreover, this approach normalizes the vegetative regulation and the erectile function. Our study included 40 patients presenting with metabolic syndrome and concomitant erectile dysfunction. All of them were treated with the use of neurostimulating therapy. It was shown that electrical stimulation of cavernous nerves and muscles of the pelvic floor improved the quality of erection, stimulated the orgasmic and ejaculatory functions, activated blood circulation in the tissues of the urogenital system, and exerted the anti-inflammatory action as well as produced the regenerative effect. It is concluded that the above changes can be accounted for by the partial restoration of vegetative and somatic innervations of the penis. This inference was confirmed by the results of repeated investigations.

Keywords

metabolic syndrome / erectile dysfunction / neurostimulating therapy

References

[1] Александров О.Б., Алехина Р.М., Григорьев С.П. и др. Метаболический синдром. Российский медицинский журнал. 2006; 6: 50-5.

[2] Мамедов М.Н. Алгоритмы диагностики и лечения метаболического синдрома в клинико-амбулаторных условиях. Кардиология. 2005; 5: 92-100.

[3] Demir T. Prevalence of erectile dysfunction in patients with metabolic syndrome. International J. of Urology. 2006; 13 (4): 385-8.

[4] Гамидов С.И. Эректильная дисфункция у больных с метаболическим синдромом: эпидемиология, патогенез, диагностика, лечение и профилактика: Дис.. д-ра мед. наук. М.; 2007.

[5] Терешин А.Т., Сосновский И.Б., Дмитренко Г.Д. Клинико-функциональное состояние пенильной гемодинамики у больных хроническим простатитом с эректильной дисфункцией. Врач-аспирант. 2012; 2 [3 (51)]: 456-66.

[6] Esposito К. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabet. Care. 2005; 28 (5): 1201-3.

[7] Ефименко А.П. Физические факторы и медикаменты в восстановительном лечении эректильной дисфункции у мужчин с метаболическим синдромом: Дис.. канд. мед. наук. Пятигорск; 2013.

[8] Ковалев В.А., Королева С.В., Камалов А.А. Фармакотерапия эректильной дисфункции. Урология. 2000; 1: 33-8.

[9] Рубин В.В. Немедикаментозная терапия эректильной дисфункции, обусловленной метаболическим синдромом, на курорте: Дис.. канд. мед. наук. Пятигорск; 2013.

[10] Раднаев В.Б. Методы рефлексотерапии в лечении и профилактике метаболического синдрома: Дис.. канд. мед. наук. М.; 2006.

[11] Бутченко Л.А., Тиктинский О.Л. Лечебная физкультура при простатите. СПб.; 1995.

[12] Мазо Е.Б., Гамидов С.И., Жученко Т.Д. и др. Левитра-тест в диагностике васкулогенной эректильной дисфункции. Урология. 2005; 1: 29-31.

RIGHTS & PERMISSIONS

Eco-Vector